Equities analysts expect Trupanion, Inc. (NASDAQ:TRUP) to report earnings of ($0.19) per share for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for Trupanion’s earnings, with estimates ranging from ($0.22) to ($0.17). Trupanion posted earnings of ($0.07) per share during the same quarter last year, which would indicate a negative year over year growth rate of 171.4%. The business is scheduled to report its next earnings report on Thursday, November 4th.
According to Zacks, analysts expect that Trupanion will report full year earnings of ($0.89) per share for the current year, with EPS estimates ranging from ($0.98) to ($0.85). For the next year, analysts anticipate that the firm will post earnings of ($0.50) per share, with EPS estimates ranging from ($0.52) to ($0.48). Zacks’ EPS averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Trupanion.
Trupanion (NASDAQ:TRUP) last issued its earnings results on Thursday, August 5th. The financial services provider reported ($0.23) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.06). Trupanion had a negative return on equity of 9.05% and a negative net margin of 4.65%. The firm had revenue of $168.26 million during the quarter, compared to the consensus estimate of $165.03 million.
Shares of NASDAQ TRUP traded down $0.61 during mid-day trading on Friday, reaching $82.35. 4,291 shares of the company’s stock were exchanged, compared to its average volume of 355,495. The firm has a 50-day moving average price of $101.11 and a two-hundred day moving average price of $92.43. Trupanion has a 52 week low of $67.15 and a 52 week high of $126.53. The firm has a market capitalization of $3.31 billion, a price-to-earnings ratio of -118.51 and a beta of 1.85.
In other news, CFO Tricia Plouf sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 15th. The stock was sold at an average price of $104.79, for a total transaction of $157,185.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Margaret Tooth sold 250 shares of the stock in a transaction that occurred on Wednesday, July 28th. The shares were sold at an average price of $114.07, for a total value of $28,517.50. Following the sale, the insider now directly owns 19,244 shares of the company’s stock, valued at approximately $2,195,163.08. The disclosure for this sale can be found here. Insiders sold a total of 26,950 shares of company stock valued at $2,670,850 over the last quarter. Company insiders own 6.77% of the company’s stock.
Several large investors have recently added to or reduced their stakes in the company. BlackRock Inc. boosted its stake in shares of Trupanion by 11.6% during the second quarter. BlackRock Inc. now owns 5,869,395 shares of the financial services provider’s stock valued at $675,565,000 after purchasing an additional 608,272 shares during the period. Vanguard Group Inc. lifted its stake in Trupanion by 2.6% in the second quarter. Vanguard Group Inc. now owns 3,769,532 shares of the financial services provider’s stock worth $433,873,000 after acquiring an additional 96,272 shares during the period. Alliancebernstein L.P. lifted its stake in Trupanion by 14.2% in the second quarter. Alliancebernstein L.P. now owns 1,320,295 shares of the financial services provider’s stock worth $151,966,000 after acquiring an additional 163,779 shares during the period. State Street Corp raised its holdings in Trupanion by 17.9% in the second quarter. State Street Corp now owns 1,206,053 shares of the financial services provider’s stock worth $138,817,000 after purchasing an additional 182,917 shares in the last quarter. Finally, Clearbridge Investments LLC raised its holdings in Trupanion by 0.3% in the second quarter. Clearbridge Investments LLC now owns 1,101,783 shares of the financial services provider’s stock worth $126,815,000 after purchasing an additional 2,937 shares in the last quarter. 81.92% of the stock is owned by hedge funds and other institutional investors.
Trupanion, Inc engages in the provision of medical insurance for cats and dogs. It operates through the following segments: Subscription Business and Other Business. The Subscription Business segment involves in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members and contracts include multiple pets.
Read More: Capital Gains
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.